(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are IDEX BIOMETRICS, IMMO MOURY, and IBA.

Financial Asset	Price	Change	Updated (EST)
IDEX BIOMETRICS (IDEX.OL)	0.20	11.35%	2024-10-11 12:40:36
IMMO MOURY (IMMOU.BR)	36.80	9.52%	2024-10-11 12:20:17
IBA (IBAB.BR)	14.26	8.52%	2024-10-11 12:20:12
KEYWARE TECH. (KEYW.BR)	0.84	8.44%	2024-10-11 12:20:29
ENSURGE MICROPOWER (ENSU.OL)	0.87	8.02%	2024-10-11 12:25:48
UNIFIEDPOST GROUP (UPG.BR)	3.76	7.45%	2024-10-11 12:21:51
DGB GROUP N.V. (DGB.AS)	0.71	6.61%	2024-10-11 12:01:37
ULTIMOVACS (ULTI.OL)	1.78	6.19%	2024-10-11 12:44:03
HYDRATEC (HYDRA.AS)	159.00	6%	2024-10-11 12:02:37
TEKNA HOLDING (TEKNA.OL)	5.02	5.71%	2024-10-11 12:43:51

The three biggest losers today are ADC SIIC, ATLANTIC SAPPHIRE, and BERGENBIO.

Financial Asset	Price	Change	Updated (EST)
ADC SIIC (ALDV.PA)	0.06	-19.46%	2024-10-11 12:44:55
ATLANTIC SAPPHIRE (ASA.OL)	0.19	-17.36%	2024-10-11 12:24:41
BERGENBIO (BGBIO.OL)	10.09	-8.46%	2024-10-11 12:24:57
HOFSETH BIOCARE (HBC.OL)	1.57	-7.94%	2024-10-11 12:40:29
NYXOAH (NYXH.BR)	8.12	-7.67%	2024-10-11 12:20:52
OXURION (OXUR.BR)	0.29	-6.45%	2024-10-11 12:20:59
BENFICA (SLBEN.LS)	3.39	-5.83%	2024-10-11 12:22:58
KENMARE RESOURCES (KMR.IR)	3.90	-5.34%	2024-10-11 12:22:41
HYBRID SOFTWARE GR (HYSG.BR)	3.52	-4.86%	2024-10-11 12:20:08
PHARMING GROUP (PHARM.AS)	0.77	-4.81%	2024-10-11 12:03:35

Winners today

1. IDEX BIOMETRICS (IDEX.OL)

11.35% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless smart cards, that includes financial payment and access control cards, as well as card-based devices for the storage of digital currencies. It primarily serves smart card manufacturers and similar solution integrators. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS jumping 11.35% to €0.20 on Friday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.4% to €1,449.34, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-1.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -217.51%.

Moving Average

IDEX BIOMETRICS’s value is way below its 50-day moving average of kr0.67 and way under its 200-day moving average of kr1.62.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IDEX BIOMETRICS’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for IDEX BIOMETRICS is 5510710 which is 26.3% above its average volume of 4363090.

More news about IDEX BIOMETRICS.

2. IMMO MOURY (IMMOU.BR)

9.52% Price Change

Immo Moury SCA is a real estate investment trust. Immo Moury SCA is based in Belgium.

BEL 20 ended the session with IMMO MOURY rising 9.52% to €36.80 on Friday, after two consecutive sessions in a row of losses. BEL 20 rose 0.86% to €4,283.23, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, IMMO MOURY has a trailing twelve months EPS of €0.95.

PE Ratio

IMMO MOURY has a trailing twelve months price to earnings ratio of 38.74. Meaning, the purchaser of the share is investing €38.74 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.71%.

Volume

Today’s last reported volume for IMMO MOURY is 1175 which is 1019.05% above its average volume of 105.

Moving Average

IMMO MOURY’s value is way higher than its 50-day moving average of €32.76 and way higher than its 200-day moving average of €31.08.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 15, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 5.99%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IMMO MOURY’s stock is considered to be oversold (<=20).

More news about IMMO MOURY.

3. IBA (IBAB.BR)

8.52% Price Change

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

BEL 20 ended the session with IBA jumping 8.52% to €14.26 on Friday while BEL 20 rose 0.86% to €4,283.23.

Earnings Per Share

As for profitability, IBA has a trailing twelve months EPS of €0.27.

PE Ratio

IBA has a trailing twelve months price to earnings ratio of 52.81. Meaning, the purchaser of the share is investing €52.81 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.86%.

More news about IBA.

4. KEYWARE TECH. (KEYW.BR)

8.44% Price Change

Keyware Technologies NV, an independent fintech company, provides electronic payments processing and management solutions in Belgium. It offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and payment processing and management services, as well as rents and sells payment terminals. The company was incorporated in 1996 and is headquartered in Zaventem, Belgium.

BEL 20 ended the session with KEYWARE TECH. jumping 8.44% to €0.84 on Friday, after four successive sessions in a row of losses. BEL 20 jumped 0.86% to €4,283.23, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, KEYWARE TECH. has a trailing twelve months EPS of €0.07.

PE Ratio

KEYWARE TECH. has a trailing twelve months price to earnings ratio of 11.93. Meaning, the purchaser of the share is investing €11.93 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.98%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 25.09M for the twelve trailing months.

Moving Average

KEYWARE TECH.’s value is way above its 50-day moving average of €0.73 and under its 200-day moving average of €0.85.

Yearly Top and Bottom Value

KEYWARE TECH.’s stock is valued at €0.84 at 22:40 EST, way below its 52-week high of €1.09 and way higher than its 52-week low of €0.65.

Volume

Today’s last reported volume for KEYWARE TECH. is 2485 which is 9.3% below its average volume of 2740.

More news about KEYWARE TECH..

5. ENSURGE MICROPOWER (ENSU.OL)

8.02% Price Change

Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 8.02% to €0.87 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.4% to €1,449.34, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-2.92.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENSURGE MICROPOWER’s stock is considered to be overbought (>=80).

Volatility

ENSURGE MICROPOWER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.59%, a negative 2.23%, and a positive 4.39%.

ENSURGE MICROPOWER’s highest amplitude of average volatility was 3.36% (last week), 5.62% (last month), and 4.39% (last quarter).

More news about ENSURGE MICROPOWER.

6. UNIFIEDPOST GROUP (UPG.BR)

7.45% Price Change

UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with UNIFIEDPOST GROUP rising 7.45% to €3.76 on Friday while BEL 20 jumped 0.86% to €4,283.23.

Earnings Per Share

As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-2.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -85.7%.

Volume

Today’s last reported volume for UNIFIEDPOST GROUP is 21150 which is 71.1% above its average volume of 12361.

Yearly Top and Bottom Value

UNIFIEDPOST GROUP’s stock is valued at €3.76 at 22:40 EST, way below its 52-week high of €4.34 and way above its 52-week low of €2.01.

Volatility

UNIFIEDPOST GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.14%, a positive 0.07%, and a positive 2.11%.

UNIFIEDPOST GROUP’s highest amplitude of average volatility was 1.44% (last week), 1.97% (last month), and 2.11% (last quarter).

More news about UNIFIEDPOST GROUP.

7. DGB GROUP N.V. (DGB.AS)

6.61% Price Change

DGB Group N.V. invests in, develops, and manages carbon credits and biodiversity projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising removing or avoiding carbon emissions, tackling social, and environmental challenges; manages projects that focuses on ecosystem restoration, habitat conservation, and biodiversity enrichment; and undertakes plastic projects, which consists of removing and recycling plastic, waste reduction, and environmental conservation works, as well as carbon offsetting projects for reducing carbon footprint of companies. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. jumping 6.61% to €0.71 on Friday, after two successive sessions in a row of losses. AEX-Index jumped 0.51% to €915.96, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.21.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.94%.

Volume

Today’s last reported volume for DGB GROUP N.V. is 64536 which is 241.11% above its average volume of 18919.

Yearly Top and Bottom Value

DGB GROUP N.V.’s stock is valued at €0.71 at 22:40 EST, way below its 52-week high of €1.03 and way higher than its 52-week low of €0.38.

More news about DGB GROUP N.V..

8. ULTIMOVACS (ULTI.OL)

6.19% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS rising 6.19% to €1.78 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.4% to €1,449.34, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.69%.

More news about ULTIMOVACS.

9. HYDRATEC (HYDRA.AS)

6% Price Change

Hydratec Industries NV, through its subsidiaries, manufactures and sells industrial systems and plastic components for food, health, and mobility markets in the Netherlands, rest of Europe, Asia, North America, South America, Africa, and Oceania. It develops and produces sterilized product handling systems; and automated packaging solutions, including packaging for sterilized food in pouches, tins, and jars, as well as meal salads and agrifood in bags, nets, boxes, and crates. The company also supplies industrial incubators to produce day-old chicks; hatchery automation systems for processing of hatchery eggs and day-old chicks; climate control equipment for air and water treatment; hatchery management software for monitoring, analyzing, and optimizing of the incubation process; and service and support for hatchery systems operation. In addition, it manufactures extrusion equipment for PVC, PVC-O, and PO pipes; plastic injection molding products for use in climate control systems, lorries, bicycle parts, and coffee machines; rubber, metal, and plastic precision components, that includes dosing systems, functional and safety parts for braking systems, and cartridges for diagnostics and other medical applications. Hydratec Industries NV is headquartered in Amersfoort, the Netherlands. Hydratec Industries NV operates as a subsidiary of Hydra Investments B.v.

AEX-Index ended the session with HYDRATEC jumping 6% to €159.00 on Friday, following the last session’s downward trend. AEX-Index jumped 0.51% to €915.96, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, HYDRATEC has a trailing twelve months EPS of €15.41.

PE Ratio

HYDRATEC has a trailing twelve months price to earnings ratio of 10.32. Meaning, the purchaser of the share is investing €10.32 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.64%.

Volume

Today’s last reported volume for HYDRATEC is 14 which is 93.3% below its average volume of 209.

More news about HYDRATEC.

10. TEKNA HOLDING (TEKNA.OL)

5.71% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING jumping 5.71% to €5.02 on Friday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.4% to €1,449.34, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.1.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.36%.

More news about TEKNA HOLDING.

Losers Today

1. ADC SIIC (ALDV.PA)

-19.46% Price Change

Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.

CAC 40 ended the session with ADC SIIC dropping 19.46% to €0.06 on Friday, after five consecutive sessions in a row of losses. CAC 40 jumped 0.48% to €7,577.89, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ADC SIIC has a trailing twelve months EPS of €-0.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.26%.

Moving Average

ADC SIIC’s value is way under its 50-day moving average of €0.07 and way under its 200-day moving average of €0.07.

Volume

Today’s last reported volume for ADC SIIC is 144992 which is 5683.49% above its average volume of 2507.

More news about ADC SIIC.

2. ATLANTIC SAPPHIRE (ASA.OL)

-17.36% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE falling 17.36% to €0.19 on Friday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.4% to €1,449.34, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-3.61.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Yearly Top and Bottom Value

ATLANTIC SAPPHIRE’s stock is valued at kr0.19 at 22:40 EST, way under its 52-week low of kr4.50.

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

More news about ATLANTIC SAPPHIRE.

3. BERGENBIO (BGBIO.OL)

-8.46% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO dropping 8.46% to €10.09 on Friday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,449.34.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-15.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

More news about BERGENBIO.

4. HOFSETH BIOCARE (HBC.OL)

-7.94% Price Change

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE dropping 7.94% to €1.57 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.4% to €1,449.34, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.34%.

Volume

Today’s last reported volume for HOFSETH BIOCARE is 122312 which is 58.26% above its average volume of 77284.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 230.08M for the twelve trailing months.

More news about HOFSETH BIOCARE.

5. NYXOAH (NYXH.BR)

-7.67% Price Change

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with NYXOAH sliding 7.67% to €8.12 on Friday, following the last session’s downward trend. BEL 20 rose 0.86% to €4,283.23, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.48.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.94%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 6.7% and a drop 70.4% for the next.

Volatility

NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was 1.62%, 1.11%, and 2.00%.

NYXOAH’s highest amplitude of average volatility was 5.03% (last week), 2.43% (last month), and 2.00% (last quarter).

More news about NYXOAH.

6. OXURION (OXUR.BR)

-6.45% Price Change

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

BEL 20 ended the session with OXURION falling 6.45% to €0.29 on Friday, after three sequential sessions in a row of losses. BEL 20 jumped 0.86% to €4,283.23, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, OXURION has a trailing twelve months EPS of €97.53.

Revenue Growth

Year-on-year quarterly revenue growth declined by 99.4%, now sitting on 84k for the twelve trailing months.

Yearly Top and Bottom Value

OXURION’s stock is valued at €0.29 at 22:40 EST, way under its 52-week low of €0.34.

More news about OXURION.

7. BENFICA (SLBEN.LS)

-5.83% Price Change

Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.

PSI ended the session with BENFICA falling 5.83% to €3.39 on Friday, following the last session’s upward trend. PSI rose 1.04% to €6,756.08, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, BENFICA has a trailing twelve months EPS of €-1.36.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BENFICA’s stock is considered to be oversold (<=20).

Volatility

BENFICA’s last week, last month’s, and last quarter’s current intraday variation average was 2.92%, 0.83%, and 2.84%.

BENFICA’s highest amplitude of average volatility was 5.94% (last week), 3.68% (last month), and 2.84% (last quarter).

Yearly Top and Bottom Value

BENFICA’s stock is valued at €3.39 at 22:40 EST, way under its 52-week high of €4.12 and way above its 52-week low of €2.62.

More news about BENFICA.

8. KENMARE RESOURCES (KMR.IR)

-5.34% Price Change

Kenmare Resources plc, together with its subsidiaries, engages in the production and sale of mineral sand products in China, the rest of Asia, Europe, the United States, and internationally. It operates the Moma Titanium Minerals Mine located on the northeast coast of Mozambique. The company's products include ilmenite, rutile, and zircon; monazite; and concentrates, including secondary zircon and mineral sand concentrates. It has a total proved and probable ore reserves of 1,429 million tons. The company was formerly known as Kenmare Oil Exploration plc and changed its name to Kenmare Resources plc in 1987. Kenmare Resources plc was incorporated in 1972 and is headquartered in Dublin, Ireland.

ISEQ All Share ended the session with KENMARE RESOURCES falling 5.34% to €3.90 on Friday while ISEQ All Share rose 0.33% to €9,734.74.

Earnings Per Share

As for profitability, KENMARE RESOURCES has a trailing twelve months EPS of €0.82.

PE Ratio

KENMARE RESOURCES has a trailing twelve months price to earnings ratio of 4.76. Meaning, the purchaser of the share is investing €4.76 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.45%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KENMARE RESOURCES’s stock is considered to be oversold (<=20).

Moving Average

KENMARE RESOURCES’s value is below its 50-day moving average of €3.91 and below its 200-day moving average of €3.93.

Volume

Today’s last reported volume for KENMARE RESOURCES is 45 which is 98.97% below its average volume of 4376.

More news about KENMARE RESOURCES.

9. HYBRID SOFTWARE GR (HYSG.BR)

-4.86% Price Change

Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom. Hybrid Software Group PLC is a subsidiary of Congra Software S.à R.L.

BEL 20 ended the session with HYBRID SOFTWARE GR dropping 4.86% to €3.52 on Friday, following the last session’s downward trend. BEL 20 rose 0.86% to €4,283.23, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.12.

PE Ratio

HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 29.33. Meaning, the purchaser of the share is investing €29.33 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.37%.

Moving Average

HYBRID SOFTWARE GR’s value is under its 50-day moving average of €3.76 and below its 200-day moving average of €3.64.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 50.06M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYBRID SOFTWARE GR’s stock is considered to be oversold (<=20).

More news about HYBRID SOFTWARE GR.

10. PHARMING GROUP (PHARM.AS)

-4.81% Price Change

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

AEX-Index ended the session with PHARMING GROUP dropping 4.81% to €0.77 on Friday while AEX-Index jumped 0.51% to €915.96.

Earnings Per Share

As for profitability, PHARMING GROUP has a trailing twelve months EPS of €-0.02.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.33%.

Volatility

PHARMING GROUP’s last week, last month’s, and last quarter’s current intraday variation average was 2.64%, 1.02%, and 2.01%.

PHARMING GROUP’s highest amplitude of average volatility was 2.64% (last week), 2.52% (last month), and 2.01% (last quarter).

Yearly Top and Bottom Value

PHARMING GROUP’s stock is valued at €0.77 at 22:40 EST, way under its 52-week high of €1.22 and way above its 52-week low of €0.65.

Sales Growth

PHARMING GROUP’s sales growth is 37.9% for the present quarter and 14.1% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PHARMING GROUP’s stock is considered to be oversold (<=20).

More news about PHARMING GROUP.

Stay up to date with our winners and losers daily report